Serial 98731414
Live / Applied — First extension granted (statement of use) (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 03 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98731414
- Mark type
- Design / logo
- Filed
- 03 Sept 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Thad Chaloemtiarana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with inflammation such as autoimmune and neurodegenerative diseases
Owner
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
- Sonoma Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 12 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 1 GRANTED
- 11 Dec 2025 — SOU EXTENSION 1 FILED
- 11 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Mar 2025 — NON-FINAL ACTION E-MAILED
- 14 Mar 2025 — NON-FINAL ACTION WRITTEN